Short description

Cell therapy, a highly anticipated field of next-generation medicine, has demonstrated promising preclinical results, but very few applications have reached the clinic owing to safety and efficacy concerns. Clinical trials of cell therapy would benefit greatly if therapeutic cell survival, distribution and function could be assessed in-vivo post-transplantation, particularly in patients. Reliable detection and the biodistribution of therapeutic cells within the entire body has long been needed to treat and alter the course of diseases which cannot be addressed adequately by existing pharmaceuticals.

LuminX Biotech dedicates to accelerate the optimization of cell-therapy-products through specific understanding of therapeutic cells distribution in-vivo, long-term viability, and their biological fate either in preclinical or clinical setting. Our technologies, LuminX Cell Therapy Enabling Platform, can transition a potential therapy from the research stage to advanced clinical and commercial applications to save lives.